Noteworthy previous studies had shown that TRIB3 promotes tumor development and resistance to therapy in triple negative breast cancer models by regulating the NOTCH pathway [33] or the stability of SOX2 via AKT inhibition and stabilization of FOXO1 [34]. The gene discussed is TRIB3; the disease is neoplasm.